Form 8-K - Current report:
SEC Accession No. 0001193125-21-270847
Filing Date
2021-09-13
Accepted
2021-09-13 07:11:33
Documents
14
Period of Report
2021-09-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d151447d8k.htm   iXBRL 8-K 31456
2 EX-10.1 d151447dex101.htm EX-10.1 61214
3 EX-99.1 d151447dex991.htm EX-99.1 6734
  Complete submission text file 0001193125-21-270847.txt   248177

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pstv-20210907.xsd EX-101.SCH 2915
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstv-20210907_lab.xml EX-101.LAB 18138
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstv-20210907_pre.xml EX-101.PRE 11423
7 EXTRACTED XBRL INSTANCE DOCUMENT d151447d8k_htm.xml XML 3395
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34375 | Film No.: 211248605
SIC: 3841 Surgical & Medical Instruments & Apparatus